IZZI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 11.904
AS - Asia 2.013
EU - Europa 1.724
Continente sconosciuto - Info sul continente non disponibili 342
SA - Sud America 333
AF - Africa 59
OC - Oceania 8
Totale 16.383
Nazione #
US - Stati Uniti d'America 11.767
SG - Singapore 799
IT - Italia 506
CN - Cina 361
BR - Brasile 269
RU - Federazione Russa 248
IE - Irlanda 192
VN - Vietnam 179
BD - Bangladesh 178
DE - Germania 173
HK - Hong Kong 164
GB - Regno Unito 137
KR - Corea 109
FR - Francia 86
UA - Ucraina 84
FI - Finlandia 81
CA - Canada 80
JP - Giappone 73
NL - Olanda 53
SE - Svezia 33
IN - India 32
AR - Argentina 23
AT - Austria 23
ID - Indonesia 23
MX - Messico 20
PL - Polonia 19
EG - Egitto 18
CZ - Repubblica Ceca 17
TR - Turchia 17
ES - Italia 16
ZA - Sudafrica 16
JM - Giamaica 12
PH - Filippine 11
BE - Belgio 10
CL - Cile 9
CR - Costa Rica 9
EC - Ecuador 9
IQ - Iraq 9
CO - Colombia 8
CH - Svizzera 7
SA - Arabia Saudita 7
GR - Grecia 6
MY - Malesia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
HN - Honduras 5
KE - Kenya 5
PE - Perù 5
RO - Romania 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
NP - Nepal 4
PK - Pakistan 4
QA - Qatar 4
TW - Taiwan 4
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
LT - Lituania 3
PY - Paraguay 3
TH - Thailandia 3
AZ - Azerbaigian 2
BB - Barbados 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AW - Aruba 1
BW - Botswana 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
GD - Grenada 1
GP - Guadalupe 1
GT - Guatemala 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NR - Nauru 1
RS - Serbia 1
SC - Seychelles 1
Totale 16.042
Città #
Wilmington 2.562
Houston 2.467
Woodbridge 1.581
Ashburn 605
Singapore 480
Fairfield 407
San Jose 352
Chandler 325
Council Bluffs 207
Seattle 202
Beijing 174
Dublin 165
Cambridge 160
Hong Kong 157
New York 156
Ann Arbor 151
Rome 125
Medford 115
Santa Clara 111
Los Angeles 107
The Dalles 78
Dearborn 72
Helsinki 56
Ho Chi Minh City 55
Lawrence 54
Buffalo 52
Milan 51
Tokyo 51
Lauterbourg 47
Dallas 46
Denver 46
Hanoi 45
Menlo Park 40
Monte Vista 40
Munich 40
Moscow 39
San Diego 36
Boardman 35
Jacksonville 34
São Paulo 33
Chicago 28
Toronto 28
Orem 27
London 23
North Bergen 22
Columbus 20
Atlanta 19
Montreal 19
Brooklyn 18
Amsterdam 17
Brno 16
Phoenix 16
Seoul 16
Stockholm 15
Boston 14
Miano 14
Norwalk 14
San Francisco 14
Warsaw 14
Jakarta 13
Manchester 13
Redwood City 13
Cairo 12
Istanbul 12
Frankfurt am Main 11
Johannesburg 11
Vienna 11
Belo Horizonte 10
Brussels 10
Da Nang 10
Las Vegas 10
Naples 10
Nuremberg 10
Salt Lake City 10
Bologna 9
Chennai 9
Kilburn 9
Mexico City 9
Washington 9
Zhengzhou 9
Haiphong 8
Lappeenranta 8
Philadelphia 8
Santiago 8
Tōyō 8
Bari 7
Guangzhou 7
Kingston 7
Mumbai 7
Nanjing 7
New Orleans 7
Palo Alto 7
San José 7
Tsu 7
Athens 6
City of London 6
Memphis 6
Newark 6
Poplar 6
Porto Alegre 6
Totale 12.272
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 517
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 494
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 490
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 479
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 459
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 440
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 436
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 435
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 434
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 403
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 398
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 386
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 382
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 379
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 373
Obstructive sleep apnoea and bone health 366
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 335
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 333
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 312
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 311
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 303
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 297
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording 280
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 278
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 274
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 273
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 271
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 263
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 256
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 251
Seasonality of restless legs syndrome: symptom variability in winter and summer times 245
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 219
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies 217
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 201
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 199
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 197
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 195
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 191
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 184
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 177
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 173
Heart rate variability parameters during psychogenic non-epileptic seizures: comparison between patients with pure PNES and comorbid epilepsy 157
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 148
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 147
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 146
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 143
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 133
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 130
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 118
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 114
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 108
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 106
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 102
Brivaracetam as early add-on treatment in patients with focal seizures: a retrospective, multicenter, real-world study 100
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 99
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 96
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 96
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 92
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series 91
Brainstem impairment in obstructive sleep apnoea and the effect of CPAP treatment: an electrophysiological blink reflex study 88
Insular monoaminergic deficits in prodromal α-synucleinopathies 87
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 81
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 78
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 77
Continuous positive airway pressure treatment improves bone mineral density in men affected by severe obstructive sleep apnea syndrome 66
Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease 61
Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance 58
OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR OSTEOPENIA AND OSTEOPOROSIS IN THE MALE POPULATION 51
Blood-brain barrier impairment as an early marker of neurodegeneration in late-onset epilepsy of unknown origin 29
Gut microbiome composition changes in obstructive sleep apnoea syndrome also in relation to excessive daytime sleepiness 28
Sex effect on time to diagnosis and clinical features of narcolepsy type 1 and 2 27
Increased neutrophil-to-lymphocyte ratio as a possible marker to detect neuroinflammation in patients with narcolepsy type 1 26
Cenobamate modulates EEG cortical activity and connectivity in individuals with drug-resistant epilepsy: a pharmaco-EEG study 25
The potential role of interleukin-6 in the association between inflammation and cognitive performance in obstructive sleep apnea 24
Sleep architecture in drug-naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy 23
The effect of lacosamide monotherapy on sleep architecture in patients with epilepsy: a preliminary evidence 23
Perampanel effects on cognition and quantitative EEG in patients with epilepsy 22
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late‐onset epilepsy of unknown aetiology: A prospective study 22
Perampanel Increases Cortical EEG Fast Activity in Child and Adult Patients Affected by Epilepsy: A Quantitative EEG Study 21
Vitamin D status of male OSAS patients improved after long-term CPAP treatment mainly in obese subjects 21
Alexithymia, impulsiveness, emotion, and eating dyscontrol: similarities and differences between narcolepsy type 1 and type 2 21
CSF dynamics of orexin and β-amyloid42 levels in narcolepsy and Alzheimer’s disease patients: a controlled study 20
Commentary: Sleep changes without medial temporal lobe or brain cortical changes in community-dwelling individuals with subjective cognitive decline 20
Persistent blood-brain barrier dysregulation in patients with obstructive sleep apnea following long-term continuous positive airway pressure treatment 19
Oral l-carnitine as treatment for narcolepsy without cataplexy during pregnancy: A case report 19
Integrating postural and vestibular dimensions to depict impairment in moderate-to-severe obstructive sleep apnea syndrome patients 18
Variability of excessive daytime sleepiness and cataplexy according to seasonality: A study in central disorders of hypersomnolence 18
Refractory restless legs syndrome remitting after dual kidney transplantation 18
Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study 18
Letter re: Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia 18
The Sleepiness–Depression Link in Obstructive Sleep Apnea: Preliminary Results on the Mediation of Impulsivity 17
null 7
Totale 16.383
Categoria #
all - tutte 54.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022562 0 0 0 11 16 18 65 15 33 53 40 311
2022/2023846 103 77 39 104 69 174 65 53 84 16 37 25
2023/2024443 43 10 24 23 36 146 21 37 8 27 6 62
2024/20251.391 62 286 148 97 36 121 67 67 142 122 140 103
2025/20263.360 251 80 332 301 243 124 398 323 328 291 471 218
2026/20271.426 443 260 583 140 0 0 0 0 0 0 0 0
Totale 16.383